101 related articles for article (PubMed ID: 28162271)
1. Nitric Oxide: Genomic Instability And Synthetic Lethality.
Yakovlev VA
Redox Biol; 2015 Aug; 5():414. PubMed ID: 28162271
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide-dependent downregulation of BRCA1 expression promotes genetic instability.
Yakovlev VA
Cancer Res; 2013 Jan; 73(2):706-15. PubMed ID: 23108140
[TBL] [Abstract][Full Text] [Related]
3. BRCA1 requirement for the fidelity of plasmid DNA double-strand break repair in cultured breast epithelial cells.
Thompson EG; Fares H; Dixon K
Environ Mol Mutagen; 2012 Jan; 53(1):32-43. PubMed ID: 22170030
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide-donor/PARP-inhibitor combination: A new approach for sensitization to ionizing radiation.
Wilson A; Menon V; Khan Z; Alam A; Litovchick L; Yakovlev V
Redox Biol; 2019 Jun; 24():101169. PubMed ID: 30889466
[TBL] [Abstract][Full Text] [Related]
5. Cells redox environment modulates BRCA1 expression and DNA homologous recombination repair.
Wilson A; Yakovlev VA
Free Radic Biol Med; 2016 Dec; 101():190-201. PubMed ID: 27771433
[TBL] [Abstract][Full Text] [Related]
6. Ataxia telangiectasia mutated and checkpoint kinase 2 regulate BRCA1 to promote the fidelity of DNA end-joining.
Wang HC; Chou WC; Shieh SY; Shen CY
Cancer Res; 2006 Feb; 66(3):1391-400. PubMed ID: 16452194
[TBL] [Abstract][Full Text] [Related]
7. [Cellular functions of BRCA genes - from basic science to therapeutics].
Miki Y
Gan To Kagaku Ryoho; 2012 Apr; 39(4):498-501. PubMed ID: 22504671
[TBL] [Abstract][Full Text] [Related]
8. Checkpoint kinase 2-mediated phosphorylation of BRCA1 regulates the fidelity of nonhomologous end-joining.
Zhuang J; Zhang J; Willers H; Wang H; Chung JH; van Gent DC; Hallahan DE; Powell SN; Xia F
Cancer Res; 2006 Feb; 66(3):1401-8. PubMed ID: 16452195
[TBL] [Abstract][Full Text] [Related]
9. Genomic Instability and Cancer Risk Associated with Erroneous DNA Repair.
Yoshioka KI; Kusumoto-Matsuo R; Matsuno Y; Ishiai M
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830134
[TBL] [Abstract][Full Text] [Related]
10. Microsatellite instability: an update.
Yamamoto H; Imai K
Arch Toxicol; 2015 Jun; 89(6):899-921. PubMed ID: 25701956
[TBL] [Abstract][Full Text] [Related]
11. MiR223-3p promotes synthetic lethality in BRCA1-deficient cancers.
Srinivasan G; Williamson EA; Kong K; Jaiswal AS; Huang G; Kim HS; Schärer O; Zhao W; Burma S; Sung P; Hromas R
Proc Natl Acad Sci U S A; 2019 Aug; 116(35):17438-17443. PubMed ID: 31395736
[TBL] [Abstract][Full Text] [Related]
12. Enhanced non-homologous end joining contributes toward synthetic lethality of pathological RAD51C mutants with poly (ADP-ribose) polymerase.
Somyajit K; Mishra A; Jameei A; Nagaraju G
Carcinogenesis; 2015 Jan; 36(1):13-24. PubMed ID: 25292178
[TBL] [Abstract][Full Text] [Related]
13. The role of the BRCA1 tumor suppressor in DNA double-strand break repair.
Zhang J; Powell SN
Mol Cancer Res; 2005 Oct; 3(10):531-9. PubMed ID: 16254187
[TBL] [Abstract][Full Text] [Related]
14. Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy.
Jiang M; Jia K; Wang L; Li W; Chen B; Liu Y; Wang H; Zhao S; He Y; Zhou C
Acta Pharm Sin B; 2021 Oct; 11(10):2983-2994. PubMed ID: 34729299
[TBL] [Abstract][Full Text] [Related]
15. PARP1-driven poly-ADP-ribosylation regulates BRCA1 function in homologous recombination-mediated DNA repair.
Hu Y; Petit SA; Ficarro SB; Toomire KJ; Xie A; Lim E; Cao SA; Park E; Eck MJ; Scully R; Brown M; Marto JA; Livingston DM
Cancer Discov; 2014 Dec; 4(12):1430-47. PubMed ID: 25252691
[TBL] [Abstract][Full Text] [Related]
16. BRCA1 regulates RAD51 function in response to DNA damage and suppresses spontaneous sister chromatid replication slippage: implications for sister chromatid cohesion, genome stability, and carcinogenesis.
Cousineau I; Abaji C; Belmaaza A
Cancer Res; 2005 Dec; 65(24):11384-91. PubMed ID: 16357146
[TBL] [Abstract][Full Text] [Related]
17. c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase-Activated Leukemias.
Muvarak N; Kelley S; Robert C; Baer MR; Perrotti D; Gambacorti-Passerini C; Civin C; Scheibner K; Rassool FV
Mol Cancer Res; 2015 Apr; 13(4):699-712. PubMed ID: 25828893
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic targeting and patient selection for cancers with homologous recombination defects.
Talens F; Jalving M; Gietema JA; Van Vugt MA
Expert Opin Drug Discov; 2017 Jun; 12(6):565-581. PubMed ID: 28425306
[TBL] [Abstract][Full Text] [Related]
19. BRCA1 role in the mitigation of radiotoxicity and chromosomal instability through repair of clustered DNA lesions.
Hair JM; Terzoudi GI; Hatzi VI; Lehockey KA; Srivastava D; Wang W; Pantelias GE; Georgakilas AG
Chem Biol Interact; 2010 Nov; 188(2):350-8. PubMed ID: 20371364
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-induced down-regulation of BRCA1 expression by E2Fs.
Bindra RS; Gibson SL; Meng A; Westermark U; Jasin M; Pierce AJ; Bristow RG; Classon MK; Glazer PM
Cancer Res; 2005 Dec; 65(24):11597-604. PubMed ID: 16357170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
